JP2022542540A5 - - Google Patents
Info
- Publication number
- JP2022542540A5 JP2022542540A5 JP2022501167A JP2022501167A JP2022542540A5 JP 2022542540 A5 JP2022542540 A5 JP 2022542540A5 JP 2022501167 A JP2022501167 A JP 2022501167A JP 2022501167 A JP2022501167 A JP 2022501167A JP 2022542540 A5 JP2022542540 A5 JP 2022542540A5
- Authority
- JP
- Japan
- Prior art keywords
- frppo
- independently
- cancer
- nhr
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19185997 | 2019-07-12 | ||
| EP19185997.4 | 2019-07-12 | ||
| PCT/EP2020/069630 WO2021009068A1 (en) | 2019-07-12 | 2020-07-10 | N-substituted-3,4-(fused 5-ring)-5-phenyl-pyrrolidine-2-one compounds as inhibitors of isoqc and/or qc enzyme |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022542540A JP2022542540A (ja) | 2022-10-05 |
| JP2022542540A5 true JP2022542540A5 (enExample) | 2023-07-18 |
Family
ID=67262155
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022501167A Pending JP2022542540A (ja) | 2019-07-12 | 2020-07-10 | ｉｓｏＱＣ及び／又はＱＣ酵素の阻害剤としてのＮ－置換－３，４－（縮合５－環）－５－フェニル－ピロリジン－２－オン化合物 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230077723A1 (enExample) |
| EP (1) | EP3997091A1 (enExample) |
| JP (1) | JP2022542540A (enExample) |
| KR (1) | KR20220054293A (enExample) |
| CN (1) | CN114466849B (enExample) |
| AU (1) | AU2020312647A1 (enExample) |
| BR (1) | BR112022000505A8 (enExample) |
| CA (1) | CA3147154A1 (enExample) |
| IL (1) | IL289784A (enExample) |
| MX (1) | MX2022000521A (enExample) |
| PH (1) | PH12022550079A1 (enExample) |
| WO (1) | WO2021009068A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3226468A1 (en) | 2021-08-02 | 2023-02-09 | Andrew Edmunds | Microbiocidal pyrazole derivatives |
| AU2022203580A1 (en) * | 2021-09-17 | 2023-04-06 | Academia Sinica | Methods of Increasing Cell Phagocytosis |
| JP2024546927A (ja) | 2021-12-17 | 2024-12-26 | シンジェンタ クロップ プロテクション アクチェンゲゼルシャフト | 殺微生物性ピラゾール誘導体 |
| TW202430514A (zh) | 2022-09-30 | 2024-08-01 | 瑞士商先正達農作物保護股份公司 | 殺微生物之吡唑衍生物 |
| PY2403614A (es) | 2023-01-27 | 2025-09-11 | Syngenta Crop Protection Ag | Derivados de pirazol microbiocidas |
| AR131665A1 (es) | 2023-02-01 | 2025-04-16 | Syngenta Crop Protection Ag | Composiciones fungicidas |
| EP4455142A1 (en) | 2023-04-26 | 2024-10-30 | Scenic Immunology B.V. | Novel inhibitor of qpctl and/or qc |
| PY2447478A (es) | 2023-06-14 | 2025-03-18 | Syngenta Crop Protection Ag | Composiciones fungicidas |
| WO2025114167A1 (en) | 2023-11-28 | 2025-06-05 | Syngenta Crop Protection Ag | Microbiocidal pyrazole derivatives |
| WO2025163143A1 (en) | 2024-02-02 | 2025-08-07 | Syngenta Crop Protection Ag | Microbiocidal pyrazole derivatives |
| WO2025191053A1 (en) | 2024-03-14 | 2025-09-18 | Syngenta Crop Protection Ag | Microbiocidal pyrazole derivatives |
| WO2025224308A1 (en) * | 2024-04-25 | 2025-10-30 | Scenic Immunology B.V. | Qpctl inhibitors |
| WO2026022173A1 (en) | 2024-07-26 | 2026-01-29 | Syngenta Crop Protection Ag | Microbiocidal pyrazole compounds |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102186475B (zh) * | 2008-09-04 | 2016-08-03 | 前体生物药物股份公司 | 新抑制剂 |
| US8975417B2 (en) * | 2013-05-27 | 2015-03-10 | Novartis Ag | Pyrazolopyrrolidine derivatives and their use in the treatment of disease |
| MX2015016421A (es) * | 2013-05-28 | 2016-03-03 | Novartis Ag | Derivados de pirazolo-pirrolidin-4-ona como inhibidores de bet y su uso en el tratamiento de enfermedades. |
| KR102084185B1 (ko) * | 2013-08-29 | 2020-03-04 | 주식회사 대웅제약 | 테트라히드로사이클로펜타피롤 유도체 및 이의 제조방법 |
| EP3747438A1 (en) * | 2017-07-24 | 2020-12-09 | Stichting Het Nederlands Kanker Instituut- Antoni van Leeuwenhoek Ziekenhuis | Treating pathological conditions by direct and indirect targeting of sirpa - cd47 interaction |
-
2020
- 2020-07-10 MX MX2022000521A patent/MX2022000521A/es unknown
- 2020-07-10 CA CA3147154A patent/CA3147154A1/en active Pending
- 2020-07-10 PH PH1/2022/550079A patent/PH12022550079A1/en unknown
- 2020-07-10 EP EP20743091.9A patent/EP3997091A1/en active Pending
- 2020-07-10 AU AU2020312647A patent/AU2020312647A1/en not_active Abandoned
- 2020-07-10 US US17/626,614 patent/US20230077723A1/en not_active Abandoned
- 2020-07-10 BR BR112022000505A patent/BR112022000505A8/pt unknown
- 2020-07-10 KR KR1020227004600A patent/KR20220054293A/ko not_active Ceased
- 2020-07-10 JP JP2022501167A patent/JP2022542540A/ja active Pending
- 2020-07-10 WO PCT/EP2020/069630 patent/WO2021009068A1/en not_active Ceased
- 2020-07-10 CN CN202080056962.2A patent/CN114466849B/zh active Active
-
2022
- 2022-01-12 IL IL289784A patent/IL289784A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022542540A5 (enExample) | ||
| AU2022200741B2 (en) | Aminothiazole compounds as c-Kit inhibitors | |
| JP7313354B2 (ja) | Ｔｌｒ阻害剤として有用なアミド置換されたインドール化合物 | |
| ES2913929T3 (es) | Compuestos químicos como inhibidores de la ruta de ATF4 | |
| JP6517928B2 (ja) | キナーゼ阻害剤として有用なインドールカルボキシアミド | |
| JP2023018094A (ja) | アロステリックｓｈｐ２阻害剤としてのピリジン化合物 | |
| JP2021506889A (ja) | Ｔｌｒ阻害剤として有効な置換されたインドール化合物 | |
| JP2020525512A (ja) | 癌および他の疾患を処置するためのＡＴＦ４阻害剤としての２−（４−クロロフェノキシ）−Ｎ−（（１−（２−（４−クロロフェノキシ）エチンアゼチジン（ｅｔｈｙｎａｚｅｔｉｄｉｎ）−３−イル）メチル）アセトアミド誘導体および関連化合物 | |
| BR112020000122A2 (pt) | derivados da n-(3-(2-(4-clorofenóxi)acetamido)biciclo[1.1.1] pentan-1-il)-2-ciclobutano-1-carboxamida e compostos relacionados como inibidores do atf4 para tratamento contra o câncer e outras doenças | |
| BR112021000332A2 (pt) | Compostos químicos | |
| CN121752574A (zh) | Kras抑制剂和其用途 | |
| JP2019521109A (ja) | 化学化合物 | |
| ES3018512T3 (es) | Inhibidores de la integrina alfa v beta6 | |
| IL273983B2 (en) | Concentrated imidazole derivatives substituted by tertiary hydroxy groups as p13k-gamma inhibitors | |
| KR20170075756A (ko) | 카르바졸 유도체 | |
| CA3093445A1 (en) | Aminopyrazine diol compounds as pi3k-.gamma. inhibitors | |
| CN105849108A (zh) | 磷脂酰肌醇3-激酶抑制剂的制备方法 | |
| JP2024545185A (ja) | ＴＬＲ７／８作動剤としてのピリド［４，３－ｄ］ピリミジン系化合物 | |
| IL281634B2 (en) | Modified diisocyclobutenylamino-3-hydroxy-picolinamide and its use as a CCR6 inhibitor | |
| AU2016334637A1 (en) | 2-oxo-1,2-dihydropyridine-3,5-dicarboxamide compounds as bromodomain inhibitors | |
| CN120040450A (zh) | 磷酸肌醇3激酶(pi3k)抑制剂的结晶形式 | |
| KR20250073137A (ko) | Egfr 억제제 및 그의 용도 | |
| HK1246778A1 (zh) | 一种新型的3-氮杂双环[3.1.0]己烷衍生物的盐的晶体以及其医药应用 | |
| WO2025024823A1 (en) | Salts and solid forms of compounds that modulate ikzf2 | |
| JP2023537994A5 (enExample) |